Correction to: Nigrostriatal tau pathology in parkinsonism and Parkinson's disease
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsParkinson's Disease Mechanisms and Treatments · Neurological disorders and treatments
Yaping Chu, Warren D. Hirst, Howard J. Federoff, Ashley S. Harms, A. Jon Stoessl, Jeffrey H. Kordower, Nigrostriatal tau pathology in parkinsonism and Parkinson's disease, Brain. 2024;147:444-457. https://doi.org/10.1093/brain/awad388
The authors apologize for errors in Fig. 6G–I, where panels G–I were a duplicate of Fig. 6D–F. In panel M, the y-axis label has been corrected from ‘TH-immunofluoresecent intensities (AFU)’ to ‘TH-immunofluorescent intensities (AFU)’.
The corrected figure is provided only in this correction notice to preserve the published version of record. These corrections do not change the manuscript's description, interpretation or original conclusions.
Corrected Figure 6: